Transgene Biotek has incorporated a wholly owned subsidiary company namely 'Peroral Bio' on December 23, 2020. The company has incorporated a wholly owned subsidiary company for carrying out the business of Pharmaceutical and biotechnology related operations and formulations.
Transgene Biotek (TBL) is engaged in manufacturing drugs for:New Drug Delivery System (NDDS)-Oral Delivery of Insulin,Oral Delivery Hepatitis B Vaccine and Pegylation of Protein Drugs.